Macrocytic anemia natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Macrocytic anemia}} | {{Macrocytic anemia}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{OK}} | ||
==Overview== | ==Overview== | ||
Revision as of 23:27, 16 October 2018
|
Macrocytic anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Macrocytic anemia natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Macrocytic anemia natural history, complications and prognosis |
|
FDA on Macrocytic anemia natural history, complications and prognosis |
|
CDC on Macrocytic anemia natural history, complications and prognosis |
|
Macrocytic anemia natural history, complications and prognosis in the news |
|
Blogs on Macrocytic anemia natural history, complications and prognosis |
|
Risk calculators and risk factors for Macrocytic anemia natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of megaloblastic anemia include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of megaloblastic anemia typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with megaloblastic anemia may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
- Common complications of megaloblastic anemia include:
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with megaloblastic anemia is approximately [--]%.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ Siddiqui B, Rabindranath D, Faridi SH, Khan AA, Haiyat S, Eswaran R (2015). "Megaloblastic anemia: A common but often neglected cause of pyrexia of unknown origin". J Transl Int Med. 3 (2): 64–67. doi:10.1515/jtim-2015-0005. PMC 4936446. PMID 27847889.